FAS and cancer: It has been hypothesized that there must be a potential correlation between FAS and mHER2 (45), with a number of studies confirming this fact, for example, in various tumors, including breast (22,46,47), ovary (20) or oral (23,48) cancer, with mHER2 and FAS upstream and downstream molecules of the PI3K and MAPK pathways.